GeneDx Holdings Corp. — Director's Dealing 2023

Nov 20, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GeneDx Holdings Corp. (WGS)
CIK: 0001818331
Period of Report: 2023-11-16

Reporting Person: Ryan Jason (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-16	Class A Common Stock	P	56742	$1.2722	Acquired	56742	Indirect
2023-11-17	Class A Common Stock	P	58000	$1.5376	Acquired	114742	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	5834	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.175 to $1.395, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.41 to $1.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.